Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | — |
I had developed CIDP/ Optic nerve inflammation/ Fatigue/ Falling/ Balance was off/ Parenthesis; Migraine; Had my thyroid removed; Tinnitus; This spontaneous case was reported by a patient and describes the occurrence of CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (I had developed CIDP/ Optic nerve inflammation/ Fatigue/ Falling/ Balance was off/ Parenthesis) and THYROID DISORDER (Had my thyroid removed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (I had developed CIDP/ Optic nerve inflammation/ Fatigue/ Falling/ Balance was off/ Parenthesis) (seriousness criteria disability and medically significant) and MIGRAINE (Migraine). In April 2021, the patient experienced THYROID DISORDER (Had my thyroid removed) (seriousness criterion medically significant) and TINNITUS (Tinnitus). The patient was treated with Surgery (Thyroid removed) for Thyroid disorder. At the time of the report, CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (I had developed CIDP/ Optic nerve inflammation/ Fatigue/ Falling/ Balance was off/ Parenthesis) outcome was unknown and THYROID DISORDER (Had my thyroid removed), TINNITUS (Tinnitus) and MIGRAINE (Migraine) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: Developed CIDP. On an unknown date, Nerve conduction studies: Developed CIDP. No concomitant medications provided by the reporter. It was reported that patient had her Moderna Covid-19 vaccination in March-2021 and April-2021. After the second Moderna Covid-19 vaccination patient had experienced sever symptom of tinnitus, fatigue optic nerve inflammation. Patient had her thyroid removed. Patient had also experienced symptom of parenthesis, migraines. Patient balance was off, and she started falling a lot. Patent had undergone tests of MRI; nerve conduction test and it was found that patient had developed CIDP. Patient had considered for a wheelchair for her filed work. Patient requested for research for her present symptom, and she would send her blood and hair sample for research. No treatment medications provided by the reporter.; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.
Test Name: MRI; Result Unstructured Data: Developed CIDP; Test Name: nerve conduction test; Result Unstructured Data: Developed CIDP